KAZFLAM-SP
| Brand Name | KAZFLAM-SP |
| Composition | Aceclofenac 100 mg, Paracetamol 325 mg and Serratiopeptidase 15 mg Tablets |
| Pack | 10×10 |
| Style | Alu/Alu |
KAZFLAM-SP brings together three active ingredients in one tablet — Aceclofenac 100 mg, Paracetamol 325 mg, and Serratiopeptidase 15 mg. It’s built as a combination formulation, pairing anti-inflammatory and analgesic action in a single dose, and should only be taken as directed by a qualified healthcare professional.
Novalab Lifecare offers this under its Tablets & Capsules range, packed 10×10 in Alu/Alu blister strips.
| Brand Name | Composition | Pack | Packing Style |
| KAZFLAM-SP | Aceclofenac 100 mg + Paracetamol 325 mg + Serratiopeptidase 15 mg | 10×10 | Alu/Alu |
Aceclofenac is an NSAID — a non-steroidal anti-inflammatory drug. Under medical supervision, it’s used to manage pain and inflammation tied to certain musculoskeletal and inflammatory conditions.
Paracetamol works as an analgesic and antipyretic — the go-to combination for managing everyday pain and bringing down fever.
Serratiopeptidase is a proteolytic enzyme. In combination formulations like this one, it’s included to support the management of inflammation and swelling alongside the other two ingredients.
Healthcare professionals may prescribe this combination in situations involving pain and inflammation, depending on how the individual patient presents and what the clinical assessment calls for.
As with any prescription combination, it should only be taken at the dosage and for the duration a qualified healthcare professional actually recommends — not self-adjusted based on how symptoms feel day to day.
Combining three ingredients with different roles gives KAZFLAM-SP a broader approach to pain and inflammation than a single-ingredient tablet would offer on its own:
The actual benefit for any individual patient still depends on their specific condition and a healthcare professional’s assessment — this isn’t a one-size-fits-all formulation.
Each ingredient plays a distinct role rather than duplicating the others’ work. Aceclofenac and Paracetamol handle pain and inflammation management from two different angles, while Serratiopeptidase contributes its proteolytic enzyme activity to the formulation.
Whether this particular combination suits a given patient comes down to their medical condition, which is exactly why it needs a healthcare professional’s judgment rather than self-selection.
Novalab Lifecare supplies KAZFLAM-SP — Aceclofenac, Paracetamol, and Serratiopeptidase Tablets — as part of its Tablets & Capsules portfolio, packed 10×10 in Alu/Alu for the pharmaceutical market and PCD franchise business.
Q.1 What is KAZFLAM-SP used for?
Ans. It’s a combination tablet used, under medical supervision, for managing pain and inflammation linked to certain musculoskeletal and inflammatory conditions.
Q.2 What are the benefits of taking Aceclofenac, Paracetamol, and Serratiopeptidase together?
Ans. Together, they address pain and inflammation from complementary angles — Aceclofenac and Paracetamol manage pain and inflammation, while Serratiopeptidase supports swelling reduction through its enzymatic action. This gives a broader effect than any one ingredient alone, though suitability still depends on the individual patient.
Q.3 Can I take KAZFLAM-SP without a prescription?
Ans. No. This is a prescription combination meant to be used only as directed by a qualified healthcare professional, at the dosage and duration they recommend.
Q.4 Are there any precautions to keep in mind?
Ans. Follow the storage instructions on the pack, keep it out of reach of children, don’t exceed the prescribed dose, and always check the batch number, manufacturing date, and expiry before use.
Q.5 Is KAZFLAM-SP available for PCD franchise business?
Ans. Yes. Novalab Lifecare offers KAZFLAM-SP as part of its Tablets & Capsules range for the pharmaceutical market and PCD franchise portfolio, supplied in 10×10 Alu/Alu packs.